Execution experience that reaches beyond consulting.
Texas Bioventures brings practical, ownership-level experience across medical device product development, regulatory execution, quality systems, documentation, commercialization, and implant technology impact.
Revenue from Involved Products
Over $200 million in revenue has been earned from products directly involving the Texas Bioventures ownership team.
Documents Developed
More than 30,000 regulatory, quality, engineering, manufacturing, operational, and product development documents have been developed by the same ownership group.
Patients Helped
More than 50,000 patients have been helped through implant devices and innovative technologies involving the Texas Bioventures consultant team.
Clarity in Complexity. Precision in Execution.
Texas Bioventures, a Veritas Prism company, provides specialized project-based consulting and interim executive support for orthopedic and spine medical device companies navigating regulatory, quality, intellectual property, engineering, manufacturing, and commercial readiness challenges.
Specialized guidance for medical device innovators.
Texas Bioventures supports orthopedic and spine medical device companies that need focused, experienced, and practical help across the full product lifecycle — from concept and IP protection through regulatory clearance preparation, quality system implementation, engineering validation, manufacturing setup, and commercial readiness.
Built for companies that need more than generic consulting.
Orthopedic and spine device companies face complex reviewer expectations, design control requirements, supplier constraints, mechanical testing considerations, technical documentation needs, and commercialization pressure.
Texas Bioventures brings clarity to these interconnected workstreams so leadership teams can make informed decisions and execute with discipline.
Focused expertise across the medical device lifecycle.
Structured support for companies preparing submissions, strengthening quality systems, protecting innovation, building documentation, qualifying suppliers, and preparing for market readiness.
Regulatory Affairs & Quality Systems
FDA 510(k), eSTAR, predicate strategy, ISO 13485, MDSAP, SOPs, CAPA, audits, FDA 483 response, and interim RA/QA leadership.
Intellectual Property Strategy
Concept refinement, patent landscape analysis, provisional patent support, professional drawings, due diligence reports, and portfolio planning.
Design Controls & Validation
DHF development, design inputs and outputs, V&V planning, test method strategy, evaluation reports, traceability, and ISO 14971 risk integration.
Manufacturing & Supplier Quality
Supplier selection, qualification, audits, quality agreements, manufacturing process development, scale-up support, and supply chain risk assessment.
Operational Excellence
Business formation support, ERP and eQMS implementation, team build-out, operating cadence, gap analyses, project management setup, and training.
Interim Executive Support
Remote or project-based C-level and VP-level leadership for organizations needing senior support across regulatory, quality, engineering, manufacturing, or operations.
Flexible support based on your business need.
Texas Bioventures can support defined projects, urgent milestones, strategic advisory needs, or interim executive leadership requirements.
Defined Project Engagements
Focused support for a specific deliverable such as a 510(k), QMS gap assessment, patent documentation package, DHF review, or supplier readiness project.
Interim Executive Support
Temporary C-level, VP-level, or senior leadership support across regulatory affairs, quality, engineering, manufacturing, operations, or commercialization planning.
Strategic Advisory Support
Periodic guidance for founders, boards, investors, or executive teams evaluating regulatory strategy, IP value, product development, or market readiness.
Need focused support for a regulatory, quality, IP, or product development milestone?
Schedule a confidential strategy call to discuss your project, timeline, current challenges, and next steps.